RE: RNS26 Apr 2019 10:19
Onwards and upwards, another brick in the wall. The building of Angle continues with another very good news release. In the time I have been invested here I have never had any reasons to believe other, than Angle was eventually going to be a ground breaking company in the quantifying of the likelihood of cancers, without the present accompanying invasive tests.